Is Royal Jelly Lipid Markers Meta-Analysis safe?

The current Migaku evidence database contains 2 reusable source documents for Royal Jelly Lipid Markers Meta-Analysis. This answer focuses on safety, limits, and clinician-discussion contexts. - Cardiovascular diseases and diabetes are associated with significant mortality, morbidity, and economic burden, highlighting the need for alternative preventive strategies. [Norouzzadeh M (2025); evidence level 1] - Honey bee products, including honey, royal jelly, and propolis, are considered potential interventions for managing cardiometabolic risk factors. [Norouzzadeh M (2025); evidence level 1] - Random-effect pairwise analysis combined trial findings, while dose-response and influence analyses assessed result robustness. [Norouzzadeh M (2025); evidence level 1] - Royal jelly, a high-value natural product rich in bioactive compounds, is highly susceptible to quality deterioration during storage and processing. [Zhang Y (2025); evidence level 3] - However, current quality standards rely predominantly on basic physicochemical parameters and measuring the content of 10-hydroxy-2-decenoic acid (10-HDA), which fail to capture the comprehensive and dynamic nature of its freshness. [Zhang Y (2025); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.